The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway

被引:352
作者
Bailey, JL
Wang, XN
England, BK
Price, SR
Ding, XY
Mitch, WE
机构
[1] Department of Medicine, Renal Division, Emory University School of Medicine, Atlanta
[2] Emory University School of Medicine, Renal Division, Box 19, Atlanta, GA 30322, 1364 Clifton Rd., N.E.
关键词
gene transcription; proteasome; ubiquitin; chronic renal failure; protein degradation;
D O I
10.1172/JCI118566
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic renal failure (CRF) is associated with negative nitrogen balance and loss of lean body mass. To identify specific proteolytic pathways activated by CRF, protein degradation was measured in incubated epitrochlearis muscles from CRF and sham-operated, pair-fed rats. CRF stimulated muscle proteolysis, and inhibition;of lysosomal and calcium-activated proteases did-not eliminate this increase. When ATP production was blocked, proteolysis in CRF muscles fell to the same level as that in control muscles. Increased proteolysis was also prevented by feeding CRF rats sodium bicarbonate, suggesting that activation depends on acidification. Evidence that the ATP-dependent ubiquitin-proteasome pathway is stimulated by the acidemia of CRF includes the following findings: (a) An inhibitor of the proteasome eliminated the increase in muscle proteolysis; and (b) there was an increase in mRNAs encoding ubiquitin (324%) and proteasome subunits C3 (137%) and C9 (251%) in muscle. This response involved gene activation since transcription of mRNAs for ubiquitin and the C3 subunit were selectively increased in muscle of CRF rats. We conclude that CRF stimulates muscle proteolysis by activating the ATP-ubiquitin-proteasome-dependent pathway. The mechanism depends on acidification and increased expression of genes encoding components of the system. These responses could contribute to the loss of muscle mass associated with CRF.
引用
收藏
页码:1447 / 1453
页数:7
相关论文
共 44 条
[1]   HINDLIMB MUSCLE FIBER POPULATIONS OF 5 MAMMALS [J].
ARIANO, MA ;
ARMSTRONG, RB ;
EDGERTON, VR .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1973, 21 (01) :51-55
[2]   EXPERIMENTAL ACIDEMIA AND MUSCLE-CELL PH IN CHRONIC ACIDOSIS AND RENAL-FAILURE [J].
BAILEY, JL ;
ENGLAND, BK ;
LONG, RC ;
WEISSMAN, J ;
MITCH, WE .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 269 (03) :C706-C712
[3]   ACTIVATION OF THE ATP-UBIQUITIN-PROTEASOME PATHWAY IN SKELETAL-MUSCLE OF CACHECTIC RATS BEARING A HEPATOMA [J].
BARACOS, VE ;
DEVIVO, C ;
HOYLE, DHR ;
GOLDBERG, AL .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (05) :E996-E1006
[4]   WHY ARE DIALYSIS PATIENTS MALNOURISHED [J].
BERGSTROM, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) :229-241
[5]   METHODS FOR ASSESSING NUTRITIONAL-STATUS OF PATIENTS WITH RENAL-FAILURE [J].
BLUMENKRANTZ, MJ ;
KOPPLE, JD ;
GUTMAN, RA ;
CHAN, YK ;
BARBOUR, GL ;
ROBERTS, C ;
SHEN, FH ;
GANDHI, VC ;
TUCKER, CT ;
CURTIS, FK ;
COBURN, JW .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (07) :1567-1585
[6]   UBIQUITIN DEPENDENCE OF SELECTIVE PROTEIN-DEGRADATION DEMONSTRATED IN THE MAMMALIAN-CELL CYCLE MUTANT TS85 [J].
CIECHANOVER, A ;
FINLEY, D ;
VARSHAVSKY, A .
CELL, 1984, 37 (01) :57-66
[7]   COMPARISON OF PROTEIN-SYNTHESIS AND DEGRADATION IN INCUBATED AND PERFUSED MUSCLE [J].
CLARK, AS ;
MITCH, WE .
BIOCHEMICAL JOURNAL, 1983, 212 (03) :649-653
[8]   MUSCLE PROTEIN-TURNOVER AND GLUCOSE-UPTAKE IN ACUTELY UREMIC RATS - EFFECTS OF INSULIN AND THE DURATION OF RENAL-INSUFFICIENCY [J].
CLARK, AS ;
MITCH, WE .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03) :836-845
[9]  
COLES GA, 1972, Q J MED, V41, P25
[10]   MUSCLE PROTEIN WASTE IN TUMOR-BEARING RATS IS EFFECTIVELY ANTAGONIZED BY A BETA(2)-ADRENERGIC AGONIST (CLENBUTEROL) - ROLE OF THE ATP-UBIQUITIN-DEPENDENT PROTEOLYTIC PATHWAY [J].
COSTELLI, P ;
GARCIAMARTINEZ, C ;
LLOVERA, M ;
CARBO, N ;
LOPEZSORIANO, FJ ;
AGELL, N ;
TESSITORE, L ;
BACCINO, FM ;
ARGILES, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2367-2372